Reslizumab
Records for this ingredient, by country (identity only).
ATC R03DX08 · 5 markets · 6 records
GB 2 records · 2 shown of 2
- 100 mg/10 mLinjectionCinqaero 100mg/10ml concentrate for solution for infusion vials
- 25 mg/2.5 mLinjectionCinqaero 100mg/10ml concentrate for solution for infusion vials
US 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionCINQAIR
CA 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedliquidCINQAIR
ES 1 records · 1 shown of 1
- 100 mg per mL / per unit basis not statedinjectionCINQAERO
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名CINQAERO ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.